Published in J Am Heart Assoc on March 23, 2015
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet (2010) 14.40
A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet (2009) 10.53
Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol (2010) 9.44
A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol (2012) 3.57
Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol (2012) 3.56
Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med (2009) 2.97
Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation (2011) 2.88
Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension (2011) 2.68
Splanchnicectomy for essential hypertension; results in 1,266 cases. J Am Med Assoc (1953) 2.58
Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmia trigger within pulmonary veins. J Am Coll Cardiol (2006) 2.57
Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis. J Am Coll Cardiol (2013) 2.29
Renal denervation in moderate to severe CKD. J Am Soc Nephrol (2012) 2.21
Renal sympathetic denervation as an adjunct to catheter ablation for the treatment of ventricular electrical storm in the setting of acute myocardial infarction. J Cardiovasc Electrophysiol (2013) 2.12
Hypertension: How should data from SYMPLICITY HTN-3 be interpreted? Nat Rev Cardiol (2014) 2.09
Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol (2009) 2.04
Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertens (2011) 1.80
Sympathetic activation in chronic renal failure. J Am Soc Nephrol (2008) 1.80
Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J (2005) 1.80
Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. Eur Heart J (2014) 1.70
Sympathetic nerve activity in end-stage renal disease. Circulation (2002) 1.67
Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol (2012) 1.66
Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol (2013) 1.65
Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol (2011) 1.58
Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension (2012) 1.54
Renal nerve ablation reduces augmentation index in patients with resistant hypertension. J Hypertens (2013) 1.54
Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension (2012) 1.52
Improvement of albuminuria after renal denervation. Int J Cardiol (2014) 1.48
First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study. Int J Cardiol (2012) 1.45
Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension (2012) 1.35
Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs. Heart Rhythm (2013) 1.21
The role of renal denervation in the treatment of heart failure. Curr Cardiol Rep (2012) 1.13
First-in-man randomized clinical trial of renal denervation for atrial arrhythmia raises concern. J Am Coll Cardiol (2013) 1.09
Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension. J Am Coll Cardiol (2012) 1.04
Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. Int J Cardiol (2013) 1.01
Renal sympathetic denervation: applications in hypertension and beyond. Nat Rev Cardiol (2013) 1.00
Effects of renal sympathetic denervation on post-myocardial infarction cardiac remodeling in rats. PLoS One (2012) 0.99
Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience. Heart Rhythm (2014) 0.93
Effects of electrical stimulation of carotid baroreflex and renal denervation on atrial electrophysiology. J Cardiovasc Electrophysiol (2013) 0.90
Effects of renal sympathetic denervation on the development of atrial fibrillation substrates in dogs with pacing-induced heart failure. Int J Cardiol (2013) 0.87
Renal denervation in human hypertension: mechanisms, current findings, and future prospects. Curr Hypertens Rep (2012) 0.84
Renal denervation prevents stroke and brain injury via attenuation of oxidative stress in hypertensive rats. J Am Heart Assoc (2013) 0.82
Renal denervation and heart failure. Eur J Heart Fail (2014) 0.80
[Comparison of efficacy between continuous positive airway pressure and renal artery sympathetic denervation by radiofrequency ablation in obstructive sleep apnea syndrome patients with hypertension]. Zhonghua Yi Xue Za Zhi (2013) 0.79
Renal sympathetic denervation does not aggravate functional or structural renal damage. J Am Coll Cardiol (2012) 0.78
Renal denervation and regression of left ventricular hypertrophy. Eur Heart J (2014) 0.77
The link between renal denervation and reduction of cardiovascular risks: simplicity or not? Int J Cardiol (2014) 0.76